Response to osimertinib following treatment with EGF816 in patients with T790M EGFR mutant NSLCLC Meeting Abstract


Authors: Arbour, K. C.; Sequist, L. V.; Piotrowska, Z.; Kris, M. G.; Paik, P. K.; Ni, A.; Plodkowski, A.; Riely, G.; Yu, H. A.
Abstract Title: Response to osimertinib following treatment with EGF816 in patients with T790M EGFR mutant NSLCLC
Meeting Title: 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 15 Suppl.
Meeting Dates: 2017 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-05-20
Language: English
ACCESSION: WOS:000411932203135
DOI: 10.1200/JCO.2017.35.15_suppl.e20673
PROVIDER: wos
Notes: Meeting Abstract: e20673 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Helena Alexandra Yu
    281 Yu
  2. Gregory J Riely
    599 Riely
  3. Paul K Paik
    255 Paik
  4. Mark Kris
    869 Kris
  5. Ai   Ni
    99 Ni
  6. Kathryn Cecilia Arbour
    88 Arbour